An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model (Clin Infect Dis 2015; 61(S1):doi:10.1093/cid/civ650) | Zendy

AI Assistant Blog Pricing

Open Access

An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model (Clin Infect Dis 2015; 61(S1):doi:10.1093/cid/civ650)

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ1189

Subject(s) - medicine , tuberculosis , drug , virology , pharmacology , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.